A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
Status:
Completed
Trial end date:
2021-02-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the long-term safety of the study drug tirzepatide
in combination with oral antihyperglycemic medications in participants with type 2 diabetes.